02.16.26 -- STREAM Edition: Building An Oral Vaccine Platform With Vaxart's Sean Tucker, Ph.D.

Our global facilities are built to guide you when you’re ready to scale; and power your mRNA journey from discovery to global commercialization with unmatched expertise and reliability.

Gain confidence in your container closure system selection by utilizing a stepwise and data-driven approach to predicting and verifying container closure integrity.

See real-world case studies showing how advanced characterization analytics and mass spectrometry resolve protein quality issues, prevent costly delays, and reduce risk across the lifecycle.

Tom Sellig, CEO, discusses the ongoing relevance of small molecules, oral solid dose development, trends like GLP-1, and innovations like 3D printing in pharmaceuticals.

In this episode of “Better Biopharma,” host Tyler Menichiello is joined by Sean Tucker, Ph.D., founder and chief scientific officer at Vaxart, a company developing oral recombinant pill vaccines.

This message highlights a CDMO site’s commitment to quality, safety, excellence, experienced staff, stable workforce, and seamless clinical‑to‑commercial transfer to support client success.